Skip to content
DataLookout
Menu

Molecular Partners AG clinical trial pipeline

Get alerts when Molecular Partners AG's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) · Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors Trial sites expanded: 6 → 9 locations Molecular Partners AGPhase 1/2 NCT07278479
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1/2
1

Disease areas by active trials

Get alerts when Molecular Partners AG's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free